1. Home
  2. EIG vs NBTX Comparison

EIG vs NBTX Comparison

Compare EIG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$41.36

Market Cap

980.0M

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$48.14

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
NBTX
Founded
2000
2003
Country
United States
France
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.0M
1.0B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
EIG
NBTX
Price
$41.36
$48.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
166.3K
62.8K
Earning Date
04-29-2026
03-31-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
$1.26
N/A
P/E Ratio
$79.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$3.64
52 Week High
$49.91
$54.74

Technical Indicators

Market Signals
Indicator
EIG
NBTX
Relative Strength Index (RSI) 47.01 66.18
Support Level $41.08 $20.11
Resistance Level $43.19 N/A
Average True Range (ATR) 1.13 2.71
MACD -0.12 1.76
Stochastic Oscillator 53.85 71.11

Price Performance

Historical Comparison
EIG
NBTX

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: